NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Laura Hurtado-Navarro, Ernesto José Cuenca-Zamora, Lurdes Zamora, Raúl Teruel-Montoya, Pablo Pelegrín, Francisca Ferrer-Marín

Journal title: Cell Reports Medicine

Journal number: Volume 4, ISSUE 12, 101329, December 19, 2023

Journal publisher: Elsevier

Published year: 2023

DOI identifier: 10.1016/j.xcrm.2023.101329

ISSN: 2666-3791